A 70-year-old with HFrEF and LVEF 25% asks about SGLT2 inhibitors. eGFR 58. What benefit is expected?...

Question

A 70-year-old with HFrEF and LVEF 25% asks about SGLT2 inhibitors. eGFR 58. What benefit is expected?

Accepted Answer

Reduced HF hospitalizations and CV death independent of diabetes

Answer

Glycemic control only

Answer

No benefit without diabetes

Answer

Renal benefit only

Answer

Risk of arrhythmia reduction only

us-abim MCQ (SBA): Heart Failure-SGLT2 Benefit